Dr Michael Banov is Medical Director of Psych Atlanta, Psych Atlanta Treatment Resistant Depression Program, and Psych Atlanta Research Center, which has offices in Marietta and Roswell, Georgia. He is also a Clinical Assistant Professor in the Department of Psychiatry at the Medical College of Georgia in Augusta, Georgia.

He is Medical Director and President of Psychsource, LLC, a not-for-profit that provides mental health information to the community. Dr Banov earned his medical degree from Emory University School of Medicine in Atlanta, Georgia. He completed a clinical fellowship in adult psychiatry at Harvard Medical School in Boston, Massachusetts. He also completed a residency where he was Chief Resident in the psychotic disorders program at Harvard Medical School.

Dr Banov is board certified by the American Board of Psychiatry and Neurology and is also certified in adolescent psychiatry and addiction psychiatry. He has given numerous presentations at national academic and medical conferences on managing and caring for patients with psychiatric disorders. He is Principal Investigator on several active clinical trials studying the safety and effects of different therapeutics to treat mental health disorders, such as anxiety, depression, and attention-deficit/hyperactivity disorder.

He has been published in several peer-reviewed journals, such as CNS Spectrums and Brain Stimulation. He is a distinguished fellow in the American Psychiatric Association and a fellow in the Academy of Physicians in Clinical Research. He has been the medical director of Psych Atlanta Ketamine, Spravato, and TMS treatment center since its inception seven years ago.